Verona Pharma plc - Depositary Receipt (Common Stock)
US ˙ NasdaqGM ˙ US9250501064
DETTE SYMBOL ER IKKE LÆNGERE AKTIVT

SecurityVRNA / Verona Pharma plc - Depositary Receipt (Common Stock)
InstitutionCitadel Advisors Llc
ManagerKen Griffin
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Citadel Advisors Llc ownership in VRNA / Verona Pharma plc - Depositary Receipt (Common Stock)

On February 17, 2026 - Citadel Advisors Llc filed a 13F-HR form disclosing ownership of 0 shares of Verona Pharma plc - Depositary Receipt (Common Stock) (US:VRNA) valued at $0 USD as of December 31, 2025. The entity filed a previous 13F-HR on November 14, 2025 disclosing 461,869 shares of Verona Pharma plc - Depositary Receipt (Common Stock). This represents a change in shares of -100.00% during the quarter. The current value of the position is $0 USD.

Citadel Advisors Llc has a history of taking positions in derivatives of the underlying security (VRNA) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

VRNA / Verona Pharma plc - Depositary Receipt (Common Stock) Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-02-17 2025-12-31 13F VERONA PHARMA SPONSORED ADS 925050106 0 -461,869 -100.00 0 -100.00
2025-11-14 2025-09-30 13F VERONA PHARMA SPONSORED ADS 925050106 461,869 -934,775 -66.93 49,286 -62.69 0.0075
2025-08-14 2025-06-30 13F VERONA PHARMA SPONSORED ADS 925050106 1,396,644 1,052,924 306.33 132,095 505.32 0.0229
2025-05-15 2025-03-31 13F VERONA PHARMA SPONSORED ADS 925050106 343,720 -1,008,993 -74.59 21,823 -65.26 0.0041
2025-02-14 2024-12-31 13F VERONA PHARMA SPONSORED ADS 925050106 1,352,713 174,691 14.83 62,820 85.36 0.0109
2024-11-14 2024-09-30 13F VERONA PHARMA SPONSORED ADS 925050106 1,178,022 1,075,407 1,048.00 33,892 2,185.30 0.0065
2024-08-14 2024-06-30 13F VERONA PHARMA SPONSORED ADS 925050106 102,615 -39,597 -27.84 1,484 -35.18 0.0003
2024-05-15 2024-03-31 13F VERONA PHARMA SPONSORED ADS 925050106 142,212 114,022 404.48 2,288 308.57 0.0004
2024-02-14 2023-12-31 13F VERONA PHARMA SPONSORED ADS 925050106 28,190 -148,293 -84.03 560 -80.53 0.0001
2023-11-14 2023-09-30 13F VERONA PHARMA SPONSORED ADS 925050106 176,483 -109,383 -38.26 2,877 -52.41 0.0006
2023-08-14 2023-06-30 13F VERONA PHARMA SPONSORED ADS 925050106 285,866 17,618 6.57 6,043 12.20 0.0012
2023-05-15 2023-03-31 13F VERONA PHARMA SPONSORED ADS 925050106 268,248 268,248 5,386 0.0012
2023-02-14 2022-12-31 13F VERONA PHARMA SPONSORED ADS 925050106 0 -695,260 -100.00 0 -100.00
2022-11-14 2022-09-30 13F VERONA PHARMA SPONSORED ADS 925050106 695,260 684,511 6,368.14 7,106 15,691.11 0.0016
2022-08-15 2022-06-30 13F VERONA PHARMA SPONSORED ADS 925050106 10,749 10,749 45 0.0000
2022-05-16 2022-03-31 13F VERONA PHARMA SPONSORED ADS 925050106 0 -11,889 -100.00 0 -100.00
2022-02-14 2021-12-31 13F VERONA PHARMA SPONSORED ADS 925050106 11,889 -10,981 -48.01 80 -36.00 0.0000
2021-11-15 2021-09-30 13F VERONA PHARMA Depository Receipt 925050106 22,870 22,870 125 0.0000
2019-08-14 2019-06-30 13F VERONA PHARMA Depository Receipt 925050106 0 -10,824 -100.00 0 -100.00
2019-05-15 2019-03-31 13F VERONA PHARMA Depository Receipt 925050106 10,824 10,824 68 0.0000
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-02-17 2025-12-31 13F VERONA PHARMA SPONSORED ADS Call 0 -100.00 0 -100.00 n/a n/a n/a
2025-11-14 2025-09-30 13F VERONA PHARMA SPONSORED ADS Call 94,100 -21.71 10,041 -11.67 n/a n/a n/a
2025-08-14 2025-06-30 13F VERONA PHARMA SPONSORED ADS Call 120,200 28.97 11,369 92.12 n/a n/a n/a
2025-05-15 2025-03-31 13F VERONA PHARMA SPONSORED ADS Call 93,200 32.01 5,917 80.51 n/a n/a n/a
2025-02-14 2024-12-31 13F VERONA PHARMA SPONSORED ADS Call 70,600 338.51 3,279 607.99 n/a n/a n/a
2024-11-14 2024-09-30 13F VERONA PHARMA SPONSORED ADS Call 16,100 -88.51 463 -77.14 n/a n/a n/a
2024-08-14 2024-06-30 13F VERONA PHARMA SPONSORED ADS Call 140,100 691.53 2,026 613.03 n/a n/a n/a
2024-05-15 2024-03-31 13F VERONA PHARMA SPONSORED ADS Call 17,700 -6.84 285 -24.67 n/a n/a n/a
2024-02-14 2023-12-31 13F VERONA PHARMA SPONSORED ADS Call 19,000 140.51 378 194.53 n/a n/a n/a
2023-11-14 2023-09-30 13F VERONA PHARMA SPONSORED ADS Call 7,900 -58.85 129 -68.40 n/a n/a n/a
2023-08-14 2023-06-30 13F VERONA PHARMA SPONSORED ADS Call 19,200 125.88 406 138.24 n/a n/a n/a
2023-05-15 2023-03-31 13F VERONA PHARMA SPONSORED ADS Call 8,500 -94.85 171 -96.06 n/a n/a n/a
2023-02-14 2022-12-31 13F VERONA PHARMA SPONSORED ADS Call 165,100 128.35 4,314 483.76 n/a n/a n/a
2022-11-14 2022-09-30 13F VERONA PHARMA SPONSORED ADS Call 72,300 56.49 739 280.93 n/a n/a n/a
2022-08-15 2022-06-30 13F VERONA PHARMA SPONSORED ADS Call 46,200 210.07 194 162.16 n/a n/a n/a
2022-05-16 2022-03-31 13F VERONA PHARMA SPONSORED ADS Call 14,900 74 n/a n/a n/a
2021-05-21 2021-03-31 13F/A VERONA PHARMA SPONSORED ADS Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-02-16 2020-12-31 13F VERONA PHARMA SPONSORED ADS Call 12,100 85 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-02-17 2025-12-31 13F VERONA PHARMA SPONSORED ADS Put 0 -100.00 0 -100.00 n/a n/a n/a
2025-11-14 2025-09-30 13F VERONA PHARMA SPONSORED ADS Put 36,500 -82.71 3,895 -80.50 n/a n/a n/a
2025-08-14 2025-06-30 13F VERONA PHARMA SPONSORED ADS Put 211,100 -11.49 19,966 31.85 n/a n/a n/a
2025-05-15 2025-03-31 13F VERONA PHARMA SPONSORED ADS Put 238,500 88.24 15,142 157.39 n/a n/a n/a
2025-02-14 2024-12-31 13F VERONA PHARMA SPONSORED ADS Put 126,700 -51.90 5,884 -22.37 n/a n/a n/a
2024-11-14 2024-09-30 13F VERONA PHARMA SPONSORED ADS Put 263,400 65.76 7,578 229.91 n/a n/a n/a
2024-08-14 2024-06-30 13F VERONA PHARMA SPONSORED ADS Put 158,900 343.85 2,298 298.78 n/a n/a n/a
2024-05-15 2024-03-31 13F VERONA PHARMA SPONSORED ADS Put 35,800 -9.14 576 -26.44 n/a n/a n/a
2024-02-14 2023-12-31 13F VERONA PHARMA SPONSORED ADS Put 39,400 0.25 783 22.34 n/a n/a n/a
2023-11-14 2023-09-30 13F VERONA PHARMA SPONSORED ADS Put 39,300 -13.05 641 -32.98 n/a n/a n/a
2023-08-14 2023-06-30 13F VERONA PHARMA SPONSORED ADS Put 45,200 99.12 956 109.89 n/a n/a n/a
2023-05-15 2023-03-31 13F VERONA PHARMA SPONSORED ADS Put 22,700 -42.39 456 -55.78 n/a n/a n/a
2023-02-14 2022-12-31 13F VERONA PHARMA SPONSORED ADS Put 39,400 1,030 n/a n/a n/a
2022-05-16 2022-03-31 13F VERONA PHARMA SPONSORED ADS Put 0 -100.00 0 -100.00 n/a n/a n/a
2022-02-14 2021-12-31 13F VERONA PHARMA SPONSORED ADS Put 12,700 85 n/a n/a n/a
2021-08-16 2021-06-30 13F VERONA PHARMA SPONSORED ADS Put 0 -100.00 0 -100.00 n/a n/a n/a
2021-05-21 2021-03-31 13F/A VERONA PHARMA SPONSORED ADS Put 11,800 -20.27 99 -4.81 n/a n/a n/a
2021-05-17 2021-03-31 13F VERONA PHARMA SPONSORED ADS Put 11,800 99 n/a n/a n/a
2021-02-16 2020-12-31 13F VERONA PHARMA SPONSORED ADS Put 14,800 104 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.